AbstractViral Hepatitis and Liver DiseaseConference on Liver Disease in Africa (COLDA) 2020COLDA_2020_abstract_66_Evaluation of the Efficacy of the Egyptian Program for Hepatitis B Virus Vaccination: A Cross Sectional National SurveyView Abstract
AbstractViral Hepatitis and Liver DiseaseConference on Liver Disease in Africa (COLDA) 2020COLDA_2020_abstract_64_Aetiology and outcomes of cirrhosis and hepatocellular carcinoma (HCC) in Queen Elizabeth Central Hospital (QECH), Blantyre, MalawiView Abstract
AbstractViral Hepatitis and Liver DiseaseConference on Liver Disease in Africa (COLDA) 2020COLDA_2020_abstract_63_Feasibility of the Public Health Approach in the Management of Hepatitis C Virus (HCV) in Nigeria, using the Pangenotypic Direct Acting Antiviral (DAAs)View Abstract
AbstractViral Hepatitis and Liver DiseaseConference on Liver Disease in Africa (COLDA) 2020COLDA_2020_abstract_62_Variceal Recurrence 4 years beyond Endoscopic Band Ligationin Hepatitis C Patients who Achieved Sustained Virological Response Post Direct Acting Antiviral Therapies.View Abstract
AbstractViral Hepatitis and Liver DiseaseConference on Liver Disease in Africa (COLDA) 2020COLDA_2020_abstract_61_Prevalence of Hepatitis B Virus and Vaccine Antibody Titers Among HIV Positive and Negative Infants in BotswanaView Abstract
AbstractViral Hepatitis and Liver DiseaseConference on Liver Disease in Africa (COLDA) 2020COLDA_2020_abstract_60_Genotype distribution of hepatitis C virus: Experience in Maputo, MozambiqueView Abstract
AbstractViral Hepatitis and Liver DiseaseConference on Liver Disease in Africa (COLDA) 2020COLDA_2020_abstract_59_Epidemiology of Hepatitis B Virus Infection in Lubumbashi, Democratic Republic of Congo: Prevalence, risk factors and Genotype Distribution among Pregnant WomenView Abstract
AbstractViral Hepatitis and Liver DiseaseConference on Liver Disease in Africa (COLDA) 2020COLDA_2020_abstract_58_The Genedrive Assay Validation: A Point of Care Testing Device for Qualitative HCV RNA DetectionView Abstract
AbstractViral Hepatitis and Liver DiseaseConference on Liver Disease in Africa (COLDA) 2020COLDA_2020_abstract_57_Infection chronique au virus de l’hépatite B (VHB) à antigène Hbe négatif au Sénégal : devenir des patients suivis à l’Hôpital Principal de DakarView Abstract
AbstractViral Hepatitis and Liver DiseaseConference on Liver Disease in Africa (COLDA) 2020COLDA_2020_abstract_56_Assessment of protective serum anti-HBsAb levels among previously HBV vaccinated medical residents and its relation to duration and doses of vaccine – single center studyView Abstract
AbstractViral Hepatitis and Liver DiseaseConference on Liver Disease in Africa (COLDA) 2020COLDA_2020_abstract_55_Safety and efficacy of different direct-acting antiviral treatment regimens in hepatitis C infected patients with renal impairment: a single center experienceView Abstract
AbstractViral Hepatitis and Liver DiseaseConference on Liver Disease in Africa (COLDA) 2020COLDA_2020_abstract_54_Risk of residual transmission of hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV) through blood transfusion in Burkina Faso: preliminary resultsView Abstract
